Rob Rosiello

Rob Rosiello joined Flagship in 2018. He focuses on boards and CEOs of Flagship-founded companies and currently serves on the board of directors of Sana Biotechnology (NASDAQ: SANA) and Seres Therapeutics (NASDAQ: MCRB).

From 1984 to 2015, Rob worked at McKinsey & Company advising CEOs and boards of leading health care, technology, and consumer companies and served on McKinsey’s Senior Partner Review and Partner Compensation Committees. He also led significant pro bono work for Save the Children, Americares, Carnegie Corporation, and Fairfield University. From July 2015 to August 2016, Rob was Executive Vice President and CFO of Valeant Pharmaceuticals, where he oversaw the finance, human resources, and IT functions of the company. During his tenure, he led Valeant’s financial restatement and regained timely reporting status with the SEC.

Rob serves on the Board of Trustees of the Marine Biological Laboratory in Woods Hole and the New England Conservatory of Music. He previously served on the boards of the Pew Research Center, Catholic Charities of New York, and of multiple Flagship-founded companies, including Inari Agriculture.

Rob received his B.A. in economics from the University of North Carolina, where he was a Morehead Scholar and graduated Phi Beta Kappa, an M.Sc. in economics from the London School of Economics, and an MBA from Harvard Business School.